TriArm Therapeutics Revenue
Biotechnology Research • • 1-10 Employees
$
TriArm Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at TriArm Therapeutics
Nicole Jha
Vice President Regulatory Affairs Quality Assurance
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
About TriArm Therapeutics
We are driving CAR T therapy innovation to make it safer and more efficacious while improving accessibility and affordability. Our platforms are designed for rapid manufacturing and improved safety of autologous CAR T therapies, expanding access for patients with unmet medical needs. Stay tuned for groundbreaking advancements as we propel this therapy into uncharted territories.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Vice President
Funding Data
TriArm Therapeutics has never raised funding before.
Australia
United Kingdom
Singapore
Frequently asked questions
TriArm Therapeutics is located in XX.
TriArm Therapeutics generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.
TriArm Therapeutics has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
TriArm Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
